William Blair Investment Management LLC Raises Holdings in Teleflex Incorporated (NYSE:TFX)

William Blair Investment Management LLC lifted its stake in Teleflex Incorporated (NYSE:TFX) by 20.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,654 shares of the medical technology company’s stock after purchasing an additional 456 shares during the quarter. William Blair Investment Management LLC’s holdings in Teleflex were worth $472,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of TFX. Victory Capital Management Inc. lifted its stake in shares of Teleflex by 364.6% during the third quarter. Victory Capital Management Inc. now owns 35,370 shares of the medical technology company’s stock worth $8,748,000 after buying an additional 27,757 shares during the period. CIBC Asset Management Inc lifted its position in Teleflex by 8.1% during the 3rd quarter. CIBC Asset Management Inc now owns 6,866 shares of the medical technology company’s stock worth $1,698,000 after acquiring an additional 517 shares during the period. Natixis Advisors LLC grew its stake in Teleflex by 4.7% during the 3rd quarter. Natixis Advisors LLC now owns 20,916 shares of the medical technology company’s stock valued at $5,173,000 after purchasing an additional 937 shares during the last quarter. Mutual of America Capital Management LLC grew its stake in Teleflex by 137.4% during the 3rd quarter. Mutual of America Capital Management LLC now owns 14,128 shares of the medical technology company’s stock valued at $3,494,000 after purchasing an additional 8,176 shares during the last quarter. Finally, Thrivent Financial for Lutherans raised its stake in shares of Teleflex by 21.3% in the third quarter. Thrivent Financial for Lutherans now owns 21,303 shares of the medical technology company’s stock worth $5,269,000 after purchasing an additional 3,736 shares during the last quarter. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on TFX. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research report on Wednesday, March 12th. Piper Sandler reaffirmed a “neutral” rating and issued a $140.00 price objective (down from $255.00) on shares of Teleflex in a report on Friday, February 28th. Wells Fargo & Company cut their price objective on shares of Teleflex from $214.00 to $146.00 and set an “equal weight” rating on the stock in a research note on Friday, February 28th. Citizens Jmp downgraded shares of Teleflex from an “outperform” rating to a “market perform” rating in a research report on Thursday, February 27th. Finally, Royal Bank of Canada downgraded Teleflex from an “outperform” rating to a “sector perform” rating and cut their price target for the stock from $220.00 to $155.00 in a research report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $182.63.

Teleflex Trading Down 0.7 %

TFX stock opened at $138.95 on Thursday. Teleflex Incorporated has a 52-week low of $128.55 and a 52-week high of $249.91. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The firm has a market cap of $6.44 billion, a P/E ratio of 27.62, a PEG ratio of 1.73 and a beta of 1.21. The company’s 50-day simple moving average is $164.60 and its 200-day simple moving average is $195.50.

Teleflex (NYSE:TFX) last issued its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.86 by $0.03. The company had revenue of $795.40 million for the quarter, compared to the consensus estimate of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. As a group, equities analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were issued a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.98%. The ex-dividend date of this dividend was Friday, March 7th. Teleflex’s payout ratio is presently 95.77%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.